A Phase II Study of Intravenous Melphalan and Busulfan Followed by HLA [human lymphocyte antigen]-Matched, Allogeneic Peripheral Blood Stem Cell Transplant for the Treatment of Multiple Myeloma.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Busulfan; Melphalan; Methotrexate; Tacrolimus
- Indications Graft-versus-host disease; Multiple myeloma
- Focus Therapeutic Use
- 21 Sep 2010 Biomarkers information updated
- 22 Apr 2008 The expected completion date for this trial is now 1 Jul 2007.
- 17 Apr 2008 Status changed from suspended to completed, reported by ClinicalTrials.gov.